Cargando…
The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
SIMPLE SUMMARY: Mucinous ovarian cancer (MOC) is a rare type of epithelial ovarian cancer, and current treatment regimens for late stage and recurrent disease are inadequate. The ‘gold standard’ treatments are based on large clinical trials that evaluated potential therapies for all ovarian cancer,...
Autores principales: | Youssef, Arkan, Haskali, Mohammad B., Gorringe, Kylie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616050/ https://www.ncbi.nlm.nih.gov/pubmed/34830751 http://dx.doi.org/10.3390/cancers13225596 |
Ejemplares similares
-
Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
por: Nugawela, Devindee, et al.
Publicado: (2023) -
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015) -
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017) -
Profiling the immune landscape in mucinous ovarian carcinoma
por: Meagher, Nicola S., et al.
Publicado: (2023) -
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018)